Complex disturbances to mineral metabolism and dysregulation of homeostasis are associated with declining kidney function in CKD [3,4,5], and a frequent complication is secondary hyperparathyroidism (SHPT), defined by elevated serum parathyroid hormone (PTH) and enlargement of the parathyroid glands [6]. The gene discussed is PTH; the disease is secondary hyperparathyroidism.